08/2025 – In alignment with our vision to create a path from adversity to health by advancing molecular diagnostics to strengthen global resilience against neglected and emerging threats, ADT Biotech is launching into orbit now as AstronDX Technologies with an exclusive focus on developing our own LyteStar and SpinStar product ranges.
Our mission is to develop innovative products to detect, monitor, and help control tropical and emerging diseases. Guided by our dictum PER ASPERA AD ASTRON, we transform scientific rigor into accessible solutions – empowering healthcare providers, supporting global disease surveillance, and making a lasting impact on public health in developing and underserved regions.
Our commitment to our partners and customers remains our highest priority and the re-alignment of focus in AstronDX does not affect marketing, sales and application support of products under distribution by AstronDX affiliates ADT Molecular Sdn Bhd and ADT India Pvt Ltd.
